Log in to save to my catalogue

Efficacy and safety of stiripentol in the prevention and cessation of status epilepticus: A systemat...

Efficacy and safety of stiripentol in the prevention and cessation of status epilepticus: A systemat...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a50466d248b041bebcfa0b2ad5688a5d

Efficacy and safety of stiripentol in the prevention and cessation of status epilepticus: A systematic review

About this item

Full title

Efficacy and safety of stiripentol in the prevention and cessation of status epilepticus: A systematic review

Publisher

United States: John Wiley & Sons, Inc

Journal title

Epilepsia open, 2024-12, Vol.9 (6), p.2017-2036

Language

English

Formats

Publication information

Publisher

United States: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Status epilepticus (SE) is a life‐threatening emergency with high morbidity and mortality. In people with epilepsy, the management of SE is focused on early medical treatment. Stiripentol is a third‐generation antiseizure medication (ASM) approved for refractory generalized tonic–clonic seizures in Dravet syndrome. The aim of this systematic review...

Alternative Titles

Full title

Efficacy and safety of stiripentol in the prevention and cessation of status epilepticus: A systematic review

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_a50466d248b041bebcfa0b2ad5688a5d

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a50466d248b041bebcfa0b2ad5688a5d

Other Identifiers

ISSN

2470-9239

E-ISSN

2470-9239

DOI

10.1002/epi4.13036

How to access this item